Skip to main content

Table 1 Baseline patients’ characteristics

From: Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study

Demographics

 Age, yr., mean (SD)

63.1 (9.2)

 Age category, n (%)

   < 65 yr

16 (53.3)

  65–74 yr

10 (33.3)

  ≥ 75 yr

4 (13.3)

 Race, n (%)

  White

30 (100)

Clinical characteristics

 Body Mass Index, kg/m2, mean (SD)

24.7 (1.8)

 Time elapsed from the diagnosis of LUTS/BPE (yr), mean (SD)

6.0 (3.9)

 Prostate volume mL, mean (SD)

58.2 (17.4)

 PVR volume, mL, mean (SD)

71.1 (33.1)

 Qmax, mL/s, mean (SD)

9.0 (2.7)

 Prostate Specific Antigen, ng/mL, mean (SD)

2.3 (1.8)

 Comorbidities, n (%)

  Hypercholesterolemia

1 (3.3)

  Asthma

1 (3.3)

  Essential hypertension

4 (13.3)

  1. SD Standard Deviation